NCT00615524 2018-01-12
Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer
GlaxoSmithKline
Phase 2 Withdrawn
Clinical Trials
5 trialsNCT02342600 2017-10-12
SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)
Sarcoma Alliance for Research through Collaboration
Phase 2 Withdrawn
NCT03149120 2017-08-22
Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas
NYU Langone Health
Phase 2 Withdrawn
NCT01179269 2016-10-12
Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer
Loyola University
Phase 2 Withdrawn
NCT02367651 2016-10-12
Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue Sarcoma
GlaxoSmithKline
Phase 2 Withdrawn